MA52936A - Composés inhibiteurs d'oga - Google Patents
Composés inhibiteurs d'ogaInfo
- Publication number
- MA52936A MA52936A MA052936A MA52936A MA52936A MA 52936 A MA52936 A MA 52936A MA 052936 A MA052936 A MA 052936A MA 52936 A MA52936 A MA 52936A MA 52936 A MA52936 A MA 52936A
- Authority
- MA
- Morocco
- Prior art keywords
- inhibitor compounds
- oga inhibitor
- oga
- compounds
- inhibitor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18382448 | 2018-06-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA52936A true MA52936A (fr) | 2021-04-28 |
Family
ID=62784075
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA052936A MA52936A (fr) | 2018-06-20 | 2019-06-20 | Composés inhibiteurs d'oga |
Country Status (8)
Country | Link |
---|---|
US (1) | US20210115040A1 (fr) |
EP (1) | EP3810136A1 (fr) |
JP (1) | JP2021527662A (fr) |
CN (1) | CN112312908A (fr) |
AU (1) | AU2019289969A1 (fr) |
CA (1) | CA3103047A1 (fr) |
MA (1) | MA52936A (fr) |
WO (1) | WO2019243528A1 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2020509004A (ja) * | 2017-02-27 | 2020-03-26 | ヤンセン ファーマシューティカ エヌ.ベー. | Oga阻害剤としての、ピペリジン、モルホリンまたはピペラジンで置換されている[1,2,4]−トリアゾロ[1,5−a]−ピリミジニル誘導体 |
WO2021094312A1 (fr) * | 2019-11-11 | 2021-05-20 | Janssen Pharmaceutica Nv | Composés inhibiteurs d'oga contenant de la pyrrolidine et de la bicyclohétéroaryle |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9243020B2 (en) * | 2010-12-23 | 2016-01-26 | Alectos Therapeutics Inc. | Selective glycosidase inhibitors and uses thereof |
JP2015531401A (ja) * | 2011-10-10 | 2015-11-02 | ハー・ルンドベック・アクチエゼルスカベット | イミダゾピラジノン骨格を有するpde9i |
WO2016030443A1 (fr) * | 2014-08-28 | 2016-03-03 | Asceneuron Sa | Inhibiteurs de glycosidases |
-
2019
- 2019-06-20 CA CA3103047A patent/CA3103047A1/fr not_active Abandoned
- 2019-06-20 MA MA052936A patent/MA52936A/fr unknown
- 2019-06-20 CN CN201980041109.0A patent/CN112312908A/zh active Pending
- 2019-06-20 EP EP19732988.1A patent/EP3810136A1/fr active Pending
- 2019-06-20 US US17/253,477 patent/US20210115040A1/en not_active Abandoned
- 2019-06-20 WO PCT/EP2019/066386 patent/WO2019243528A1/fr unknown
- 2019-06-20 JP JP2020570695A patent/JP2021527662A/ja active Pending
- 2019-06-20 AU AU2019289969A patent/AU2019289969A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20210115040A1 (en) | 2021-04-22 |
WO2019243528A1 (fr) | 2019-12-26 |
AU2019289969A1 (en) | 2020-12-17 |
JP2021527662A (ja) | 2021-10-14 |
CA3103047A1 (fr) | 2019-12-26 |
EP3810136A1 (fr) | 2021-04-28 |
CN112312908A (zh) | 2021-02-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA52942A (fr) | Composés inhibiteurs d'oga | |
MA52939A (fr) | Composés inhibiteurs d'oga | |
MA47575A (fr) | Composés inhibiteurs d'oga monocyclique | |
MA47576A (fr) | Composés inhibiteurs d'oga bicyclique | |
MA47420A (fr) | Composés inhibiteurs d'oga | |
MA52486A (fr) | Pyridazinones utilisés en tant qu'inhibiteurs de parp7 | |
MA52489A (fr) | Nouveaux composés | |
MA52948A (fr) | Composés | |
MA44725A (fr) | Formulations d'un inhibiteur de lsd1 | |
MA52967A (fr) | Composés antagonistes du pcsk9 | |
MA51669A (fr) | Composés | |
MA51616A (fr) | Inhibiteurs d'adn-pk | |
MA52004A (fr) | Inhibiteurs d'o-glycoprotéine-2-acétamido-2-désoxy-3-d-glycopyranosidase | |
DK3687994T3 (da) | Gadolinium-bærende pcta-baserede kontrastmidler | |
MA53003A (fr) | Composés | |
UA42295S (uk) | Комп'ютер | |
MA46652A (fr) | Polythérapie pour l'inhibition de c3 | |
MA54521A (fr) | Dérivés d'oxopyridine substitués | |
MA46242A (fr) | Composés inhibiteurs de bêta-lactamase | |
DK3762368T3 (da) | Aminopyrazindiolforbindelser som pi3k-y-inhibitorer | |
MA49006A (fr) | Inhibiteurs d'ip6k | |
DK3737677T3 (da) | Tetrahydroisoquinolinforbindelser | |
UA42369S (uk) | Комп'ютер | |
MA52946A (fr) | Composés | |
MA53430A (fr) | Nouveaux composés |